Tongrentang has two listed companies at home and abroad, more than 600 chain stores and branches around the world, 20 overseas joint ventures and stores in 2/kloc-0 countries and regions, and its products are sold to more than 40 countries and regions. Five production bases have been established in Beijing Daxing, Yizhuang, Liujiayao, Tongzhou, Changping and Tongrentang, with 4/kloc-0 production lines, which can produce 26 dosage forms and more than 1,000 products. ?
All production lines have passed the national GMP certification, and the 10 production line has passed the Australian TGA certification. Tongrentang Chinese Medicine Co., Ltd., an overseas production base established with an investment of HK$ 654.38+0.5 billion in 2004, passed GMP certification at the end of 2005, laying a good foundation for the internationalization of production, R&D and marketing.
In the 4th and 5th "Top 50 Listed Companies with the Most Development Potential in China" jointly sponsored by china securities journal Shangya Enterprise Consulting Co., Ltd., Tongrentang Co., Ltd. ranked first. Science and Technology Development Co., Ltd. is one of the best performing stocks on Hong Kong Growth Enterprise Market, and the enterprise has achieved a virtuous circle.